Safety and Efficacy of Donor T-lymphocytes Depleted ex Vivo of Host Alloreactive T-cells (ATIR) in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor
Clinical trial NCT01794299 · COMPLETED
Trial details
- NCT number
- NCT01794299
- Sponsor
- Kiadis Pharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2016-06-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.